APA

Nair K. V., Tang B., Van Den Bos J., Zhang V., Saseen J. J., Naim A. & Rahman M. (20090414). Categorization of infliximab dose changes and healthcare utilization and expenditures for patients with rheumatoid arthritis in commercially insured and Medicare-eligible populations. : Current medical research and opinion.

Chicago

Nair Kavita V, Tang Boxiong, Van Den Bos Jill, Zhang Vicki, Saseen Joseph J, Naim Ahmad and Rahman Mirza. 20090414. Categorization of infliximab dose changes and healthcare utilization and expenditures for patients with rheumatoid arthritis in commercially insured and Medicare-eligible populations. : Current medical research and opinion.

Harvard

Nair K. V., Tang B., Van Den Bos J., Zhang V., Saseen J. J., Naim A. and Rahman M. (20090414). Categorization of infliximab dose changes and healthcare utilization and expenditures for patients with rheumatoid arthritis in commercially insured and Medicare-eligible populations. : Current medical research and opinion.

MLA

Nair Kavita V, Tang Boxiong, Van Den Bos Jill, Zhang Vicki, Saseen Joseph J, Naim Ahmad and Rahman Mirza. Categorization of infliximab dose changes and healthcare utilization and expenditures for patients with rheumatoid arthritis in commercially insured and Medicare-eligible populations. : Current medical research and opinion. 20090414.